- Home
- CARG vs DNLI Comparison
CARG vs DNLI Comparison
Compare CARG & DNLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CARG | DNLI |
|---|---|---|
| Founded | 2005 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 3.2B |
| IPO Year | 2017 | 2017 |
Fundamental Metrics
Financial Performance| Metric | CARG | DNLI |
|---|---|---|
| Price | $34.41 | $19.72 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 11 |
| Target Price | ★ $38.29 | $30.00 |
| AVG Volume (30 Days) | ★ 1.6M | 1.4M |
| Earning Date | 05-22-2026 | 05-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 675.00 | N/A |
| EPS | ★ 1.55 | N/A |
| Revenue | ★ $316,861,000.00 | N/A |
| Revenue This Year | $11.80 | N/A |
| Revenue Next Year | $7.89 | $291.12 |
| P/E Ratio | $21.70 | ★ N/A |
| Revenue Growth | ★ 59.92 | N/A |
| 52 Week Low | $24.65 | $10.57 |
| 52 Week High | $39.42 | $23.77 |
Technical Indicators
Market Signals| Indicator | CARG | DNLI |
|---|---|---|
| Relative Strength Index (RSI) | 64.11 | 45.90 |
| Support Level | $33.31 | $13.28 |
| Resistance Level | $36.23 | $20.12 |
| Average True Range (ATR) | 1.54 | 1.11 |
| MACD | 0.88 | -0.15 |
| Stochastic Oscillator | 91.54 | 25.00 |
Price Performance
Historical ComparisonAbout CARG CarGurus Inc.
CarGurus Inc is a company that acts as an online automotive marketplace connecting buyers and sellers of new and used cars. The company provides three types of marketplace Listing products, Restricted Listings, and Enhanced or Featured Listings, through which it offers real-time and historical data analyzing the connections and pricing analysis. The listing platforms offer auto manufacturers and others to buy advertising on the company's site and target consumers based on the make, model, and zip code of the cars. The company operates through two segments, namely U.S. Marketplace and Digital Wholesale. It generates maximum revenue from the U.S. Marketplace segment. Geographically, the company derives its key revenue from the United States and the rest from international markets.
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.